BC
ZYME icon

Brookfield Corp’s Zymeworks ZYME Stock Holding History

Brookfield Corp’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-63,032
Closed -$545K – 544
2023
Q2 		$545K Buy
+63,032
New +$564K ﹤0.01% 498
2023
Q1 		– Sell
-741,186
Closed -$5.83M – 811
2022
Q4 		$5.83M Buy
741,186
+537,534
+264% +$3.78M 0.02% 235
2022
Q3 		$1.25M Buy
203,652
+51,218
+34% +$309K ﹤0.01% 512
2022
Q2 		$808K Buy
152,434
+25,304
+20% +$153K ﹤0.01% 521
2022
Q1 		$833K Buy
+127,130
New +$1.13M ﹤0.01% 520

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return